{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:40:21Z","timestamp":1770061221300,"version":"3.49.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Reactive arthritis(ReA), a form of arthritis occurring post-infection, manifests with antecedent infection symptoms, arthritis, and extra-articular manifestations, categorizing it as spondyloarthritis. \u201cKeratoderma blennorrhagicum\u201d (characterized by pustular hyperkeratosis on palms and soles, resembling pustular psoriasis) represents the most typical skin manifestation of ReA, occurring in acute or chronic phases. Severe lesions necessitate systemic disease modifying anti-rheumatic drugs (DMARDs) or biologic therapies. This article reports a case of ReA with sacroiliitis and widespread pustular eruptions following a urinary tract infection. Treatment with sulfasalazine and thalidomide significantly improved sacroiliitis, but the skin rash remained persistent and recurring. Subsequent use of adalimumab and secukinumab resulted in worsening skin rash, prompting a switch to tofacitinib, leading to a remarkable improvement in pustular eruptions after 20 days of treatment. This case demonstrates successful application of tofacitinib in treating severe keratoderma blennorrhagicum refractory to conventional DMARDs and biologics, offering insights into JAK inhibition for challenging rheumatic diseases with skin involvement.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1399249","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:24:12Z","timestamp":1719894252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Maierhaba","family":"Maitiyaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nueramina","family":"Keyimu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueqiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuilian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations","volume":"17","author":"Colmegna","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12741","article-title":"Reactive arthritis","volume":"29","author":"Stavropoulos","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02847","article-title":"Emerging topical and systemic JAK inhibitors in dermatology","volume":"10","author":"Solimani","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.005","article-title":"Diagnosis and classification of reactive arthritis","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.047","article-title":"Reiter\u2019s syndrome: the classic triad and more","volume":"59","author":"Wu","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0956462414540617","article-title":"2014 European Guideline on the management of sexually acquired reactive arthritis","volume":"25","author":"Carlin","year":"2014","journal-title":"Int J STD AIDS"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: The promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-7-41","article-title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","volume":"7","author":"Meyer","year":"2010","journal-title":"J Inflammation (Lond)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14749","article-title":"Keratinocytes activated by IL-4\/IL-13 express IL-2R\u03b3 with consequences on epidermal barrier function","volume":"32","author":"Progneaux","year":"2023","journal-title":"Exp Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13115","article-title":"IL-17A promotes neutrophilic inflammation and disturbs acute wound healing in skin","volume":"26","author":"Takagi","year":"2017","journal-title":"Exp Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/all.14791","article-title":"Interleukin-31: The \u201citchy\u201d cytokine in inflammation and therapy","volume":"76","author":"Datsi","year":"2021","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.12.657","article-title":"Cross-talk between IFN-\u03b3 and TWEAK through miR-149 amplifies skin inflammation in psoriasis","volume":"147","author":"Srivastava","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.07.010","article-title":"The role of Janus kinase signaling in the pathology of atopic dermatitis","volume":"152","author":"Guttman-Yassky","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxab029","article-title":"Successful use of tofacitinib in reactive arthritis refractory to conventional therapies - a case series","volume":"6","author":"Maikap","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13117","article-title":"Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report","volume":"61","author":"Haynes","year":"2020","journal-title":"Australas J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S421299","article-title":"Refractory palmoplantar pustulosis successfully treated with JAK inhibitor tofacitinib: A case series","volume":"16","author":"Xu","year":"2023","journal-title":"Infect Drug Resist"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1399249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:24:14Z","timestamp":1719894254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1399249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":16,"alternative-id":["10.3389\/fimmu.2024.1399249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1399249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"article-number":"1399249"}}